Clinical trial
An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine
NCT01578941 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- September 30, 2012
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
menstrual migraine